Abstract:Aptamers are functional nucleic acids that bind to a range of targets (small molecules, proteins or cells) with a high affinity and specificity. Chemically-modified aptamers are of interest because the incorporation of novel nucleobase components can enhance aptamer binding to target proteins, while fluorescent base analogues permit the design of functional aptasensors that signal target binding. However, since optimally modified nucleoside designs have yet to be identified, information about how to fine tune aptamer stability and target binding affinity is required. The present work uses molecular dynamics (MD) simulations to investigate modifications to the prototypical thrombin-binding aptamer (TBA), which is a 15-mer DNA sequence that folds into a G-quadruplex structure connected by two TT loops and one TGT loop. Specifically, we modeled a previously synthesized thymine (T) analog, namely 5-furyl-2′-deoxyuridine (5FurU), into each of the six aptamer locations occupied by a thymine base in the TT or TGT loops of unbound and thrombin bound TBA. This modification and aptamer combination were chosen as a proof-of-principle because previous experimental studies have shown that TBA displays emissive sensitivity to target binding based on the local environment polarity at different 5FurU modification sites. Our simulations reveal that the chemically-modified base imparts noticeable structural changes to the aptamer without affecting the global conformation. Depending on the modification site, 5FurU performance is altered due to changes in the local environment, including the modification site structural dynamics, degree of solvent exposure, stacking with neighboring bases, and interactions with thrombin. Most importantly, these changes directly correlate with the experimentally-observed differences in the stability, binding affinity and emissive response of the modified aptamers. Therefore, the computational protocols implemented in the present work can be used in subsequent studies in a predictive way to aid the fine tuning of aptamer target recognition for use as biosensors (aptasensors) and/or therapeutics.

Alkylation of Phosphorothioated Thrombin Binding Aptamers Improves the Selectivity of Inhibition of Tumor Cell Proliferation Upon Anticoagulation.

Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivatives

Selective Alkylation and Bioactivity of Phosphorothioated Nucleolin Aptamer AS1411

Molecular assembly for high-performance bivalent nucleic acid inhibitor

Selective Recognition of Co-Assembled Thrombin Aptamer and Docetaxel on Mesoporous Silica Nanoparticles Against Tumor Cell Proliferation.

Anticoagulant Oligonucleotide–Peptide Conjugates: Identification of Thrombin Aptamer Conjugates with Improved Characteristics

A sensitive thrombin-linked sandwich immunoassay for protein targets using high affinity phosphorodithioate modified aptamer for thrombin labeling.

NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6C<SUP>low</SUP> Monocytes/Macrophages Differentiation to Accelerate Thrombolysis

Treating Tissue Factor-Positive Cancers with Antibody-Drug Conjugates That Do Not Affect Blood Clotting

Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation

Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy

Stability and Bioactivity of Thrombin Binding Aptamers Modified with D-/L-Isothymidine in the Loop Regions

Thioflavin T as a fluorescence light-up probe for both parallel and antiparallel G-quadruplexes of 29-mer thrombin binding aptamer

Regulating the Properties of XQ-2d for Targeted Delivery of Therapeutic Agents to Pancreatic Cancers.

Regulating the properties of XQ-2d for targeted therapeutic agents delivery to pancreatic cancer

Selective Anti-melanoma Effect of Phosphothioated Aptamer Encapsulated by Neutral Cytidinyl/Cationic Lipids

TBA loop mapping with 3′-inverted-deoxythymidine for fine-tuning of the binding affinity for α-thrombin

High-Sensitive Determination Of Human Alpha-Thrombin By Its 29-Mer Aptamer In Affinity Probe Capillary Electrophoresis

Improving Tumor Accumulation of Aptamers by Prolonged Blood Circulation.

Impact of the Position of the Chemically Modified 5-Furyl-2′-Deoxyuridine Nucleoside on the Thrombin DNA Aptamer–Protein Complex: Structural Insights into Aptamer Response from MD Simulations

A responsive disulfide bond switch aptamer prodrug exhibiting enhanced stability and anticancer efficacy